Next Generation Sequencing Market: Growth, Size, Share, and Trends

Report Code BT 2697
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

Overview

The global next-generation sequencing market, valued at US$12.13 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$12.65 billion in 2024 and an impressive US$23.55 billion by 2029. The primary growth drivers of the NGS market are the rising demand for precision medicine in identifying genetic mutations & biomarkers, which have enabled targeted therapies and advanced precision medicine initiatives globally. The declining cost of sequencing has broadened its adoption in large-scale projects and routine diagnostics.

Next-Generation Sequencing Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Next-Generation Sequencing Market

Asia Pacific

The growth of the Asia Pacific NGS market is primarily due to the rising funding for Translational research bolstered by the region’s diverse population with unique genetic backgrounds and healthcare challenges.

Growth in this market is primarily driven by technological advancement in NGS sequencing.

Rising demand of healthcare testing to support clinical genomics is driving the demand of NGS market

High investments to develop advanced sequencing technologies restrain the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The rising investments by governments in Translational research to drive growth.

Global Next-Generation Sequencing Market Dynamics

DRIVER: Advancement in sequencing platforms

Advances in the sequencing platform are highly driving NGS, making it much more efficient, accurate, and accessible with high throughput, which researchers have been able to sequence larger genomes and various samples in a single run compared to earlier times, thus reducing the cost and time. The sequencing chemistries, such as the improvement in fluorescent labeling and error correction mechanisms, have enhanced the accuracy and quality of data.

NGS has become a relatively accessible tool in smaller laboratories and clinics by way of development into automated compact systems, benchtop sequencers, as well. The workflow on platforms supports all applications that involve targeted sequencing, transcriptomics, and epigenetics and integrating advanced tools with bioinformatics that simplify analysis processes. Also, improvements in scalability allow users the chance to pick a platform that goes well with the size and budget of their project and spans from small-scale studies to large population genomics projects.

RESTRAINT: High initial capital investment

High initial capital investment is one of the significant restraints for the NGS market, limiting its adoption, especially in smaller labs, academic institutions, and emerging markets. The purchase price of advanced sequencing instruments ranges from hundreds of thousands to millions of dollars, which makes it a heavy financial burden. A setup of an NGS facility, for example, would need the infrastructure investments into data storage and high-performance computing systems and lab automation tools. Cost implications would therefore arise in continuous personnel training and equipment maintenance together with the constant procurement of consumables.

To these costs of high upfront and operationally, for many potential users, outsourcing sequencing services becomes a much practical option rather than investing in-house capabilities. This financial barrier slows down the adoption of NGS technology in less-funded research projects, small-scale clinical diagnostics, and resource-constrained regions, which restricts the overall market growth.

 

OPPORTUNITY: Increasing use of genomics in precision medicine

The adoption of long-read sequencing technologies presents significant opportunities in the NGS market by addressing critical challenges associated with short-read methods. Long-read platforms, such as those offered by Pacific Biosciences and Oxford Nanopore Technologies, enable the sequencing of longer DNA or RNA fragments, providing more comprehensive and accurate genome assemblies. This is especially useful in the analysis of complex genomic regions, such as structural variations, repetitive sequences, and phased haplotypes, which are challenging to resolve with short-read technologies. Applications like de novo genome assembly, full-length transcriptomics, and epigenetic studies have created an increased demand, which has led to the penetration of long-read technologies.

In addition, improvements in accuracy, throughput, and cost reductions are making these technologies increasingly available for further extensive research and more clinical use. The segment where researchers increasingly seek to complement short-read methods by long-read sequencing is thus a high-growth business within the NGS market.

CHALLENGES: Standardization Issues

Standardization issues pose a significant challenge in the NGS market, impacting the reproducibility, reliability, and scalability of sequencing workflows. The lack of uniform protocols for sample preparation, library construction, and data analysis leads to variability in results across different laboratories and platforms. This inconsistency can hinder the comparability of datasets and complicate multi-center studies or collaborative research projects. In clinical applications, the absence of standardized guidelines for test validation and regulatory compliance, particularly across different regions, creates hurdles for the widespread adoption of NGS-based diagnostics. Moreover, diverse bioinformatics tools and data formats further exacerbate the challenge, making it difficult to integrate and analyze data seamlessly.

Addressing these standardization issues is crucial to ensure high-quality results, foster trust in NGS technologies, and enable broader adoption across research and clinical domains.

Global Next-Generation Sequencing Market Ecosystem Analysis

Global Next-generation sequencing market Ecosystem Analysis includes technology developers, consumables suppliers, product & service providers, and end-users such as research institutions, clinical labs, hospitals, and biotechnology companies. Regulatory authorities and standards bodies also play pivotal roles, influencing market trends, innovation, and the ethical use of NGS data. Understanding this complex network is crucial for navigating and driving advancements in sequencing technologies.

Next-Generation Sequencing Market Ecosystem
 

The product segment accounted for the largest share by offerings segment in the next-generation sequencing market in 2023.

By offerings, the next-generation sequencing market is segmented into products and services. The next-generation sequencing market has the highest market share in products since it plays a critical role in the accomplishment of various research, diagnostic, and therapeutic applications. A huge demand for instruments, consumables, and reagents is generated due to the wide use of sequencing technologies. The importance of these tools is the main key in conducting sequencing analysis starting from sample preparation and moving up to data interpretation for wide applications. The rising interest in personalized medicine, cancer research, and disease diagnosis has steadily increased the demand for sequencing products. Genome-based tests for precision medicine require a robust pipeline of reliable products that will accurately and expeditiously identify genetic variations. In the research environment, advanced instruments and reagents are needed to study gene expression, epigenetic modifications, and genome-wide associations. Continuous advances in product innovation, like more efficient and cost-effective sequencing technologies, have only continued to expand the genomics user base across pharmaceutical companies, academic institutions, and healthcare providers. This should ensure that products remain at the heart of driving the next-generation sequencing market forward while offering cutting-edge research and clinical advancements.

The sequencing technology segment accounted for the largest share by platform technology segment in the next-generation sequencing market in 2023.

By platform technology, the NGS market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing accounted for the largest share of the market in 2023. Because of its low error rates and high-quality data characterize SBS technology, which makes it the go-to choice for critical applications like whole-genome and clinical sequencing. The widespread use of SBS in applications such as genomics, transcriptomics, epigenomics, and metagenomics expands its market penetration. It also supports both high-throughput sequencing for large-scale projects and smaller-scale applications, making it versatile for various research and clinical needs. Illumina's leadership in the NGS market, with its SBS-based systems, has played a major role in the adoption of this technology.

The cancer diagnostics segment accounted for the largest share of the diagnostic application segment in the next-generation sequencing market in 2023.

By diagnostic application, the next-generation sequencing market is segmented into cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, and other diagnostic applications. In 2023, the cancer diagnostics segment accounted for the largest share of the next-generation sequencing market. This can be attributed to the ability to rising prevalence of cancer types and increasing demand for their extensive genomic profiling. NGS is significant in cancer detection, diagnosis, and treatment due to the genetically driven nature of the disease. In effect, mutations and DNA changes cause the abnormal cell proliferation that constitutes cancer by definition. Genomics technologies, such as next-generation sequencing and other molecular diagnostic tools, have the potential to perform in-depth profiling of these kinds of mutations, and better and earlier detection of cancers. One of the leading factors for oncology dominating diagnostic use is precision medicine. It facilitates tumor genomic profiling, therefore targeting mutations for oncologists when treating individual patients by guiding oncologists to proper therapy targeted for the given patients. The results have greatly improved with such cancers like lung, breast, and colorectal cancer whose particular alterations can be matched against proper treatments. Technologies are increasingly employed in the monitoring of the therapeutic response and detection of minimal residual disease. A greater share in the diagnostic segment has come for oncology on account of rising worldwide burdens of cancer together with availability-based improvements of NGS-based tests; that promise transformational benefits of early detection, better prognosis, and optimum selection of therapy.

The North American Region Accounted for the Largest Share of the Next-Generation Sequencing Market in 2023.

The next-generation sequencing market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for genomics in 2023, while Europe is the second-largest market. The large share of North America can be attributed to the growing acceptance and integration of WGS in healthcare, as well as the government initiatives and policies to integrate NGS in healthcare further supporting the market growth. Another factor that explains why North America has a gigantic share is the generous funding and support for genomics research coming from the government and private sectors. For example, the All of US Research Program is a large-scale program aimed at generating huge quantities of genomic data to improve healthcare outcomes and subsequently spur an increase in demand for sequencing technologies. In fact, many research institutes and universities in the United States and Canada have been highly involved in sequencing work that has accelerated innovations in cancer genomics, pharmacogenomics, and population genomics. Advanced healthcare infrastructure in North America has also helped advance sequencing technologies into the clinic. Growth has been fueled further by increased demand for personalized medicine, particularly in oncology, through an increased demand for NGS-based diagnostics and targeted therapy.

However, the Asia Pacific is estimated to be the fastest-growing segment of the market owing to the increasing application in clinical diagnostics, and the the growing focus on custom tailored medicine.

HIGHEST CAGR MARKET IN 2024
NORTH AMERICA FASTEST GROWING MARKET IN THE REGION FASTEST GROWING MARKET IN THE REGION
Next-Generation Sequencing Market Region

Recent Developments of Next-Generation Sequencing Market

  • In May 2024, Oxford Nanopore Technologies collaborated with Twist Bioscience to launch a new Pharmacogenomics Beta Programme. This long-read pharmacogenomics solution, available for research use, is designed to provide clear genetic results in a single end-to-end workflow from sample to pharmacogenomics star allele call.
  • In September 2023, PacBio announced a partnership with Hamilton, Integra, Revvity, and Tecan to create fully automated protocols to prepare samples for sequencing on Revio and Sequel II and IIe systems.

Key Market Players

KEY PLAYERS IN THE NEXT-GENERATION SEQUENCING MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Next-Generation Sequencing Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered Offerings, Product Type, Platform Technology, Product Workflow, Product End User, Service Type, Service Workflow, Service End User, Application
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

 

Key Questions Addressed by the Report

Who are the key players in the next-generation sequencing market?
Key players in the global next-generation sequencing market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), and Agilent Technologies, Inc. (US)
Which offering dominates the next-generation sequencing market?
The products segment dominated the next-generation sequencing market in 2023.
Which application segment of the global next-generation sequencing market is expected to witness the highest growth?
The diagnostics segment is expected to witness the highest growth, attributed to its detection of dna variations, comprehensive genomic information, and high-quality genome assemblies.
What is the market size for the next-generation sequencing market?
The market size of the next-generation sequencing market in 2023 was USD 12.13 billion.
What is the growth rate of the next-generation sequencing market?
The next-generation sequencing market is expected to reach USD 23.55 billion in 2029 from USD 12.65 billion in 2024, at a CAGR of 13.2% during the forecast period.

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Next-Generation Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
56
RESEARCH METHODOLOGY
61
EXECUTIVE SUMMARY
73
PREMIUM INSIGHTS
78
MARKET OVERVIEW
81
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Advancements in sequencing platforms
    - Rising clinical applications of sequencing
    - Growing demand for precision medicine
    - Declining costs of sequencing
    RESTRAINTS
    - Data analysis complexity
    - High capital investment and expenses
    OPPORTUNITIES
    - Integration of AI and ML
    - Adoption of long-read sequencing technologies
    - Emphasis on multiomics integration
    CHALLENGES
    - Standardization issues
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Sequencing by synthesis
    - Single-molecule real-time sequencing
    - Nanopore sequencing
    - Ion semiconductor sequencing
    COMPLEMENTARY TECHNOLOGIES
    - Automated sample preparation systems
    - Bioinformatics and data analysis platforms
    - CRISPR-based targeted sequencing
    - Multiplex PCR
    ADJACENT TECHNOLOGIES
    - Single-cell sequencing technology
    - Multi-omics integration
    - Spatial genomics and transcriptomics
    - Gene editing technologies
  • 5.7 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    - Average selling price trend of instruments, by key player, 2018–2023
    - Average selling price trend of consumables, by key player, 2022–2024
    - Average selling price of services, by key player, 2024
    AVERAGE SELLING PRICE, BY REGION
  • 5.8 PATENT ANALYSIS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA, BY END USER
  • 5.14 INVESTMENT AND FUNDING SCENARIO
  • 5.15 CASE STUDY ANALYSIS
    CASE STUDY 1: IDENTIFYING TANDEM REPEAT LINKED TO ALS USING SMRT SEQUENCING
    CASE STUDY 2: LONG-READ WHOLE-GENOME SEQUENCING AT CHILDREN’S MERCY KANSAS CITY
    CASE STUDY 3: SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
  • 5.16 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.17 IMPACT OF AI ON NEXT-GENERATION SEQUENCING MARKET
NEXT-GENERATION SEQUENCING MARKET, BY OFFERING
122
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    WIDE DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
  • 6.3 SERVICES
    SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE
131
  • 7.1 INTRODUCTION
  • 7.2 CONSUMABLES
    LIBRARY PREPARATION & AND REAGENTS
    - Strong demand and growing applications to ensure market growth
    SEQUENCING KITS & REAGENTS
    - Technological advancements to support market growth
    OTHER CONSUMABLES
  • 7.3 PLATFORMS
    SEQUENCING PLATFORMS
    - Illumina
    - Thermo Fisher Scientific
    - PacBio
    - Oxford Nanopore Technologies
    - Other sequencing platforms
    LIBRARY PREPARATION PLATFORMS
    - Rising demand for sequencing in clinical applications to drive market
  • 7.4 BIOINFORMATICS TOOLS
    DATA ANALYSIS SOFTWARE & WORKBENCHES
    - Demand for genome analysis in clinical diagnostics to support market growth
    DATA VISUALIZATION TOOLS
    - Rising demand for sequencing-based research to support market growth
    OTHER BIOINFORMATICS TOOLS
NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY
180
  • 8.1 INTRODUCTION
  • 8.2 SEQUENCING BY SYNTHESIS
    HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION
  • 8.3 ION SEMICONDUCTOR SEQUENCING
    SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
  • 8.4 SMRT SEQUENCING
    RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET
  • 8.5 NANOPORE SEQUENCING
    DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND
  • 8.6 OTHER SEQUENCING TECHNOLOGIES
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW
201
  • 9.1 INTRODUCTION
  • 9.2 SEQUENCING
    DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET
  • 9.3 PRESEQUENCING
    DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET GROWTH
  • 9.4 DATA ANALYSIS
    DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE MARKET
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER
214
  • 10.1 INTRODUCTION
  • 10.2 ACADEMIC & RESEARCH INSTITUTES
    RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
  • 10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET
  • 10.4 CLINICAL & DIAGNOSTIC LABORATORIES
    INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
  • 10.5 OTHER END USERS
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE
230
  • 11.1 INTRODUCTION
  • 11.2 SEQUENCING SERVICES
    EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
    - Development of technologically advanced NGS products and services to propel growth
    RNA SEQUENCING
    - Technological advancements to support market growth
    DE NOVO SEQUENCING
    - Rising awareness of De Novo sequencing to drive market
    CHIP SEQUENCING
    - Increased demand for ChIP sequencing to propel growth
    WHOLE-GENOME SEQUENCING
    - Reduced cost of WGS to support market growth
    METHYL SEQUENCING
    - Increased demand for methyl sequencing in cancer research to support market growth
    OTHER SEQUENCING SERVICES
  • 11.3 PRESEQUENCING SERVICES
    LIBRARY PREPARATION & TARGET ENRICHMENT
    - Development of advanced library preparation solutions to drive market
    SAMPLE PREPARATION
    - Development of automated sample preparation solutions to boost growth
    QUALITY CONTROL
    - Importance of quality control in NGS workflow to boost growth
  • 11.4 BIOINFORMATICS & DATA ANALYSIS SERVICES
    DATA ANALYSIS
    - Increasing demand for genome analysis for clinical diagnosis to drive market
    DATA VISUALIZATION & INTERPRETATION
    - Rising demand for sequencing-based research to support market growth
    DATA STORAGE & MANAGEMENT
    - Demand for effective data management to propel market growth
  • 11.5 NGS PLATFORM SERVICES
    NEED FOR COMPLIANCE AND MINIMIZING PLATFORM DOWNTIME TO DRIVE ADOPTION
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW
291
  • 12.1 INTRODUCTION
  • 12.2 SEQUENCING
    RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
  • 12.3 PRESEQUENCING SERVICES
    CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH
  • 12.4 DATA ANALYSIS SERVICES
    RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER
303
  • 13.1 INTRODUCTION
  • 13.2 ACADEMIC & RESEARCH INSTITUTES
    RISING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH
  • 13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH
  • 13.4 HOSPITALS & CLINICAL LABORATORIES
    INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
  • 13.5 OTHER END USERS
NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
319
  • 14.1 INTRODUCTION
  • 14.2 DIAGNOSTICS
    CANCER DIAGNOSTICS
    - Rising demand for targeted therapies to drive market
    INFECTIOUS DISEASE DIAGNOSTICS
    - Rising demand for comprehensive genomic data in clinical diagnostics to propel adoption
    REPRODUCTIVE HEALTH DIAGNOSTICS
    - Focus on genetic disease diagnostics to drive growth
    OTHER DIAGNOSTIC APPLICATIONS
  • 14.3 DRUG DISCOVERY & DEVELOPMENT
    PHARMACOGENOMICS
    - Rising use of NGS for understanding genomic variants in humans to drive growth
    OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS
  • 14.4 AGRICULTURE & ANIMAL RESEARCH
    EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS
  • 14.5 OTHER APPLICATIONS
NEXT-GENERATION SEQUENCING MARKET, BY REGION
357
  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - US expected to dominate market in North America
    CANADA
    - Increasing government initiatives in sequencing research to boost market growth
  • 15.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Germany to dominate European NGS market
    UK
    - Strategic initiatives and funding for genomics research to support market growth
    FRANCE
    - Increasing government investment in genomics research to drive growth
    ITALY
    - Favorable funding scenario to drive adoption of advanced sequencing technology
    SPAIN
    - Growing focus on advancements in personalized medicine to support market growth
    NETHERLANDS
    - Well-established research infrastructure to sustain demand for NGS
    REST OF EUROPE
  • 15.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - China to dominate Asia Pacific market during forecast period
    JAPAN
    - Rising number of collaborations in NGS to drive market
    INDIA
    - Government and private initiatives for genomics projects to propel market
    AUSTRALIA
    - Increased genetic research in Australia to support market growth
    SOUTH KOREA
    - Demand for advanced sequencing technologies to support market growth in South Korea
    REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Increased government investments in genomics advancements to drive market
    MEXICO
    - Rising demand for chronic disease treatment to support market growth in Mexico
    REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST
    MIDDLE EAST: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 15.7 AFRICA
    GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
573
  • 16.1 INTRODUCTION
  • 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET
  • 16.3 REVENUE ANALYSIS, 2019–2023
  • 16.4 MARKET SHARE ANALYSIS, 2023
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Offering footprint
    - Application footprint
    - Technology footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of startups/SMEs
  • 16.7 VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 16.8 BRAND/PRODUCT COMPARISON
  • 16.9 COMPETITIVE SCENARIO
    DEALS
    EXPANSIONS
COMPANY PROFILES
593
  • 17.1 KEY PLAYERS
    ILLUMINA, INC.
    - Business overview
    - Products/services offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/services offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/services offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/services offered
    - Recent developments
    DANAHER CORPORATION
    - Business overview
    - Products/services offered
    - Recent developments
    QIAGEN
    - Business overview
    - Products/services offered
    - Recent developments
    REVVITY
    - Business overview
    - Products/services offered
    - Recent developments
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/services offered
    - Recent developments
    PACBIO
    - Business overview
    - Products/services offered
    - Recent developments
    OXFORD NANOPORE TECHNOLOGIES PLC.
    - Business overview
    - Products/services offered
    - Recent developments
    TAKARA BIO INC.
    - Business overview
    - Products/services offered
    - Recent developments
    BGI GROUP
    - Business overview
    - Products/services offered
    - Recent developments
    BD
    - Business overview
    - Products/services offered
    - Recent developments
    10X GENOMICS
    - Business overview
    - Products/services offered
    - Recent developments
    PROMEGA CORPORATION
    - Business overview
    - Products/services offered
    - Recent developments
    LGC LIMITED
    - Business overview
    - Products/services offered
    WUXI BIOLOGICS
    - Business overview
    - Products/services offered
    TECAN TRADING AG
    - Business overview
    - Products/services offered
    TWIST BIOSCIENCES
    - Business overview
    - Products/services offered
    - Recent developments
    AZENTA US, INC.
    - Business overview
    - Products & services offered
    - Recent developments
  • 17.2 OTHER PLAYERS
    MGI TECH CO. LTD.
    NOVOGENE CO., LTD.
    NEW ENGLAND BIOLABS
    GENSCRIPT
    PSOMAGEN
    ZYMO RESEARCH CORPORATION
    HAMILTON COMPANY
    NEOGENOMICS LABORATORIES
    FULGENT GENETICS
    SD BIOSENSOR, INC.
APPENDIX
704
  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 NGS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
  • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 9 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD)
  • TABLE 11 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
  • TABLE 12 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
  • TABLE 13 INNOVATIONS AND PATENT REGISTRATIONS, 2020–2024
  • TABLE 14 NGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 15 NGS MARKET: LIST OF KEY CONFERENCES AND EVENTS
  • TABLE 16 NGS MARKET: IMPACT OF PORTER’S FIVE FORCES
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 18 KEY BUYING CRITERIA, BY END USER
  • TABLE 19 IMPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 20 IMPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)
  • TABLE 21 EXPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 22 EXPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)
  • TABLE 23 NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 24 NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 EUROPE: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 39 NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 47 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 OTHER NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 EUROPE: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: OTHER NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 GCC COUNTRIES: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (UNITS)
  • TABLE 86 NOVASEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 NEXTSEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 MISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 89 MINISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 ISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 91 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 94 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 101 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 108 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 123 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,2022–2029 (USD MILLION)
  • TABLE 131 NGS TECHNOLOGIES, BY COMPANY
  • TABLE 132 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 133 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 141 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 146 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 160 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 162 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 167 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 169 NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 EUROPE: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 MIDDLE EAST: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 EUROPE: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 MIDDLE EAST: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 189 GCC COUNTRIES: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 191 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 197 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 218 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 229 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 MIDDLE EAST: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 RNA SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 236 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 250 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 265 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 269 GCC COUNTRIES: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 271 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 278 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 286 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 287 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 290 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 291 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 293 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 298 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 QUALITY CONTROL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 300 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 301 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 303 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 305 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 306 NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 307 NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 308 EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 310 LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 312 GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 313 NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 DATA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 315 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 316 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 318 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 319 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 320 GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 321 DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 322 NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 323 EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 325 LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 326 MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 328 DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 329 NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 330 EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 332 LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 333 MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 334 GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 335 NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 336 NORTH AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 337 EUROPE: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 339 LATIN AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 340 MIDDLE EAST: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 341 GCC COUNTRIES: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 342 NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 343 NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 344 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 345 EUROPE: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 350 NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 351 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 352 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 354 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 357 NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 358 NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 359 EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 361 LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 362 MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 364 NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 365 NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 366 NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 367 EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 369 LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 370 MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 372 NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 373 NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 374 EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 375 ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 376 LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 377 MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 378 GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 379 NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 380 NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 381 EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 383 LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 384 MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 385 GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 386 NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 387 NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 388 EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 390 LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 391 MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 392 GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 393 NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 394 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 395 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 396 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 397 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 399 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 401 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)
  • TABLE 403 NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 404 NORTH AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 405 EUROPE: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 406 ASIA PACIFIC: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 407 LATIN AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST: NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 410 NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 411 NORTH AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 412 EUROPE: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 413 ASIA PACIFIC: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 414 LATIN AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 417 NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 418 NORTH AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 419 EUROPE: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 420 ASIA PACIFIC: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 421 LATIN AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 422 MIDDLE EAST: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 423 GCC COUNTRIES: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 424 NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 425 NORTH AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 426 EUROPE: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 427 ASIA PACIFIC: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 428 LATIN AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 429 MIDDLE EAST: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 430 GCC COUNTRIES: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 431 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 432 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 433 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 435 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 436 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 438 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 439 NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 440 NORTH AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 441 EUROPE: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 442 ASIA PACIFIC: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 444 MIDDLE EAST: NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 445 GCC COUNTRIES: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 446 NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 447 NORTH AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 448 EUROPE: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 449 ASIA PACIFIC: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 450 LATIN AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 451 MIDDLE EAST: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 452 GCC COUNTRIES: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 453 NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 454 NORTH AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 455 EUROPE: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 456 ASIA PACIFIC: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 458 MIDDLE EAST: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 459 GCC COUNTRIES: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 460 NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 461 NORTH AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 462 EUROPE: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 463 ASIA PACIFIC: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 464 LATIN AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 465 MIDDLE EAST: NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 466 GCC COUNTRIES: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 467 NGS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 468 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 469 NORTH AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 470 NORTH AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 471 NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 472 NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 474 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 475 NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 476 NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 477 NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 478 NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 480 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 481 NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 483 NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 484 NORTH AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 485 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 486 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 US: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 488 US: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 489 US: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 US: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 491 US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 493 US: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 494 US: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 495 US: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 US: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 US: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 US: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 US: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 500 US: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 501 US: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 502 US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 CANADA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 505 CANADA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 507 CANADA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 508 CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 510 CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 511 CANADA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 512 CANADA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 513 CANADA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 CANADA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 CANADA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 516 CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 517 CANADA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 518 CANADA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 519 CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 EUROPE: KEY MACROINDICATORS
  • TABLE 522 EUROPE: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 523 EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 524 EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 528 EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 529 EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 530 EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 531 EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 535 EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 536 EUROPE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 537 EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 538 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 540 GERMANY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 541 GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 543 GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 546 GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 547 GERMANY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 548 GERMANY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 GERMANY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 GERMANY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 GERMANY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 552 GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 553 GERMANY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 554 GERMANY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 555 GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 UK: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 558 UK: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 559 UK: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 UK: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 561 UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 562 UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 563 UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 564 UK: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 565 UK: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 566 UK: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 567 UK: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 568 UK: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 569 UK: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 570 UK: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 571 UK: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 572 UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 574 FRANCE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 575 FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 576 FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 577 FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 578 FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 580 FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 581 FRANCE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 582 FRANCE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 583 FRANCE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 584 FRANCE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 FRANCE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 586 FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 587 FRANCE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 588 FRANCE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 589 FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 590 FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 ITALY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 592 ITALY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 593 ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 ITALY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 595 ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 596 ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 597 ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 598 ITALY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 599 ITALY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 600 ITALY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 601 ITALY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 ITALY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 604 ITALY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 605 ITALY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 606 ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 607 ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 608 SPAIN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 609 SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 610 SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 611 SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 612 SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 613 SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 614 SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 615 SPAIN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 616 SPAIN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 617 SPAIN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 SPAIN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 619 SPAIN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 620 SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 621 SPAIN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 622 SPAIN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 623 SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 625 NETHERLANDS: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 626 NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 627 NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 628 NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 629 NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 631 NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 632 NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 633 NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 634 NETHERLANDS: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 635 NETHERLANDS: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 NETHERLANDS: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 637 NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 638 NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 639 NETHERLANDS: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 640 NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 641 NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 642 REST OF EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 643 REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 644 REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 645 REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 648 REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 649 REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 650 REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 651 REST OF EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 652 REST OF EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 653 REST OF EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 654 REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 655 REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 656 REST OF EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 657 REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 658 REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 659 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 660 ASIA PACIFIC: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 661 ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 662 ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 663 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 664 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 665 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 666 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 667 ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 668 ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 669 ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 670 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 671 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 672 ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 673 ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 674 ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 675 ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 676 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 677 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 678 CHINA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 679 CHINA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 680 CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 681 CHINA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 682 CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 683 CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 684 CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 685 CHINA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 686 CHINA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 687 CHINA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 688 CHINA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 689 CHINA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 690 CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 691 CHINA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 692 CHINA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 693 CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 694 CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 695 JAPAN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 696 JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 697 JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 698 JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 699 JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 700 JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 701 JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 702 JAPAN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 703 JAPAN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 704 JAPAN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 705 JAPAN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 706 JAPAN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 707 JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 708 JAPAN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 709 JAPAN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 710 JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 711 JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 712 INDIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 713 INDIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 714 INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 715 INDIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 716 INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 717 INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 718 INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 719 INDIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 720 INDIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 721 INDIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 722 INDIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 723 INDIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 724 INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 725 INDIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 726 INDIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 727 INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 728 INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 729 AUSTRALIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 730 AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 731 AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 732 AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 733 AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 734 AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 735 AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 736 AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 737 AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 738 AUSTRALIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 739 AUSTRALIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 740 AUSTRALIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 741 AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 742 AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 743 AUSTRALIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 744 AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 745 AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 746 SOUTH KOREA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 747 SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 748 SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 749 SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 750 SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 751 SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 752 SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 753 SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 754 SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 755 SOUTH KOREA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 756 SOUTH KOREA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 757 SOUTH KOREA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 758 SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 759 SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 760 SOUTH KOREA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 761 SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 762 SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 763 REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 764 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 765 REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 766 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 767 REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 768 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 769 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 770 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 771 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 772 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 773 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 774 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 775 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 776 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 777 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 778 REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 779 REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 780 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 781 LATIN AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 782 LATIN AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 783 LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 784 LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 785 LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 786 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 787 LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 788 LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 789 LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 790 LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 791 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 792 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 793 LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 794 LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 795 LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 796 LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 797 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 798 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 799 BRAZIL: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 800 BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 801 BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 802 BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 803 BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 804 BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 805 BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 806 BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 807 BRAZIL: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 808 BRAZIL: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 809 BRAZIL: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 810 BRAZIL: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 811 BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 812 BRAZIL: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 813 BRAZIL: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 814 BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 815 BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 816 MEXICO: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 817 MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 818 MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 819 MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 820 MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 821 MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 822 MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 823 MEXICO: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 824 MEXICO: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 825 MEXICO: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 826 MEXICO: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 827 MEXICO: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 828 MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 829 MEXICO: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 830 MEXICO: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 831 MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 832 MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 833 REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 834 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 835 REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 836 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 837 REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 838 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 839 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 840 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 841 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 842 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 843 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 844 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 845 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 846 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 847 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 848 REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 849 REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 850 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 851 MIDDLE EAST: NGS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 852 MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 853 MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 854 MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 855 MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 856 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 857 MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 858 MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 859 MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 860 MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 861 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 862 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 863 MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 864 MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 865 MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 866 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 867 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 868 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 869 GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 870 GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 871 GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 872 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 873 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 874 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 875 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 876 GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 877 GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 878 GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 879 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 880 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 881 GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 882 GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 883 GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 884 GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 885 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 886 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 887 SAUDI ARABIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 888 SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 889 SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 890 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 891 SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 892 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 893 SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 894 SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 895 SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 896 SAUDI ARABIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 897 SAUDI ARABIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 898 SAUDI ARABIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 899 SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 900 SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 901 SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 902 SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 903 SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 904 UAE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 905 UAE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 906 UAE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 907 UAE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 908 UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 909 UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 910 UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 911 UAE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 912 UAE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 913 UAE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 914 UAE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 915 UAE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 916 UAE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 917 UAE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 918 UAE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 919 UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 920 UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 921 REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 922 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 923 REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 924 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 925 REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 926 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 927 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 928 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 929 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 930 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 931 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 932 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 933 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 934 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 935 REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 936 REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 937 REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 938 REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 939 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 940 REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 941 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 942 REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 943 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 944 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 945 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 946 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 947 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 948 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 949 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 950 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 951 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 952 REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 953 REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 954 REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 955 MACROECONOMIC OUTLOOK FOR NGS MARKET IN AFRICA
  • TABLE 956 AFRICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 957 AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 958 AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 959 AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 960 AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 961 AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 962 AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 963 AFRICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 964 AFRICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 965 AFRICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 966 AFRICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 967 AFRICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 968 AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 969 AFRICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 970 AFRICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 971 AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 972 AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 973 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NGS MARKET
  • TABLE 974 NGS MARKET: DEGREE OF COMPETITION
  • TABLE 975 NGS MARKET: REGION FOOTPRINT
  • TABLE 976 NGS MARKET: OFFERING FOOTPRINT
  • TABLE 977 NGS MARKET: APPLICATION FOOTPRINT
  • TABLE 978 NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 979 NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 980 NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 981 NGS MARKET: DEALS, JANUARY 2021– DECEMBER 2024
  • TABLE 982 NGS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 983 ILLUMINA: COMPANY OVERVIEW
  • TABLE 984 ILLUMINA: PRODUCTS/SERVICES OFFERED
  • TABLE 985 ILLUMINA: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 986 ILLUMINA: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 987 ILLUMINA: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 988 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 989 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 990 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 991 THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 992 THERMO FISHER SCIENTIFIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 993 AGILENT TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 994 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
  • TABLE 995 AGILENT TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 996 AGILENT TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 997 AGILENT TECHNOLOGIES: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 998 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
  • TABLE 999 F. HOFFMANN-LA ROCHE: PRODUCTS/SERVICES OFFERED
  • TABLE 1000 F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1001 F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1002 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 1003 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 1004 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1005 DANAHER CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1006 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 1007 QIAGEN: COMPANY OVERVIEW
  • TABLE 1008 QIAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 1009 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1010 QIAGEN: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1011 QIAGEN: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 1012 REVVITY: COMPANY OVERVIEW
  • TABLE 1013 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 1014 REVVITY: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1015 REVVITY: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1016 REVVITY: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 1017 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 1018 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 1019 EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1020 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1021 PACBIO: COMPANY OVERVIEW
  • TABLE 1022 PACBIO: PRODUCTS/SERVICES OFFERED
  • TABLE 1023 PACBIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1024 PACBIO: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1025 PACBIO: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 1026 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 1027 OXFORD NANOPORE TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 1028 OXFORD NANOPORE TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
  • TABLE 1029 OXFORD NANOPORE TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1030 OXFORD NANOPORE TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1031 TAKARA BIO: COMPANY OVERVIEW
  • TABLE 1032 TAKARA BIO: PRODUCTS/SERVICES OFFERED
  • TABLE 1033 TAKARA BIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1034 TAKARA BIO: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1035 BGI GROUP: COMPANY OVERVIEW
  • TABLE 1036 BGI GROUP: PRODUCTS/SERVICES OFFERED
  • TABLE 1037 BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1038 BGI GROUP: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1039 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 1040 BD: COMPANY OVERVIEW
  • TABLE 1041 BD: PRODUCTS/SERVICES OFFERED
  • TABLE 1042 BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1043 BD: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1044 10X GENOMICS: COMPANY OVERVIEW
  • TABLE 1045 10X GENOMICS: PRODUCTS/SERVICES OFFERED
  • TABLE 1046 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1047 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 1048 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 1049 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 1050 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 1051 LGC LIMITED: PRODUCTS/SERVICES OFFERED
  • TABLE 1052 LGC LIMITED: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1053 WUXI BIOLOGICS: COMPANY OVERVIEW
  • TABLE 1054 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
  • TABLE 1055 TECAN TRADING AG: COMPANY OVERVIEW
  • TABLE 1056 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
  • TABLE 1057 TECAN TRADING AG: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1058 TWIST BIOSCIENCE: COMPANY OVERVIEW
  • TABLE 1059 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
  • TABLE 1060 TWIST BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 1061 TWIST BIOSCIENCE: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 1062 AZENTA US: COMPANY OVERVIEW
  • TABLE 1063 AZENTA US: PRODUCTS & SERVICES OFFERED
  • TABLE 1064 AZENTA US: DEALS, JANUARY 2021–DECEMBER 2024
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 NGS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 3 NGS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 NGS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 NGS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 NGS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 NGS PLATFORMS MARKET, BY TECHNOLOGY 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 NGS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 NGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 NGS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 NGS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 17 TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING TO DRIVE MARKET GROWTH
  • FIGURE 18 CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN ASIA PACIFIC IN 2023
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 20 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE PRODUCTS MARKET DURING FORECAST PERIOD
  • FIGURE 21 NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS
  • FIGURE 23 NGS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 VALUE CHAIN ANALYSIS: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE
  • FIGURE 25 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 26 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2024 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE OF SERVICES, 2024 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
  • FIGURE 29 PATENT ANALYSIS FOR NGS MARKET, 2014–2024
  • FIGURE 30 NGS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 NGS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 NGS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 34 KEY BUYING CRITERIA, BY END USER
  • FIGURE 35 RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2020–2024 (USD MILLION)
  • FIGURE 36 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
  • FIGURE 37 NORTH AMERICA: NGS MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: NGS MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN NGS MARKET, 2019–2023 (USD MILLION)
  • FIGURE 40 NGS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 41 NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 42 NGS MARKET: COMPANY FOOTPRINT
  • FIGURE 43 NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 ILLUMINA: COMPANY SNAPSHOT (2023)
  • FIGURE 48 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 49 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)
  • FIGURE 50 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)
  • FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 53 REVVITY: COMPANY SNAPSHOT (2023)
  • FIGURE 54 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 55 PACBIO: COMPANY SNAPSHOT (2023)
  • FIGURE 56 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2023)
  • FIGURE 57 TAKARA BIO: COMPANY SNAPSHOT (2023)
  • FIGURE 58 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 59 10X GENOMICS: COMPANY SNAPSHOT (2023)
  • FIGURE 60 LGC LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 61 WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
  • FIGURE 62 TECAN TRADING AG: COMPANY SNAPSHOT (2023)
  • FIGURE 63 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
  • FIGURE 64 AZENTA US: COMPANY SNAPSHOT (2023)

 

This study on the next-generation sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the next-generation sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

Secondary Research

The secondary sources referred to for this research study include publications from government sources. These include the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), the World Health Organization (WHO), the American Cancer Society (ACS), the National Center for Biotechnology Information (NCBI), the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), International Agency for Research on Cancer (IARC), National Institute for Infectious Diseases (IRCCS), Association for Clinical Genomic Science (ACGS), American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG), Asia Pacific Society of Human Genetics (APSHG), Nature Reviews Genetics, Nature Methods, Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Genome Research, National Cancer Institute (NCI), European Medicines Agency (EMA), Population Health Research Institute (PHRI), PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global next-generation sequencing market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global next-generation sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing NGS; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Next-Generation Sequencing Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the next-generation sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Next-Generation Sequencing Market

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

NGS refers to non-Sanger-based, high-throughput DNA sequencing technologies. DNA strands can be sequenced simultaneously, yielding substantially more throughput and minimizing the need for fragment-cloning methods often used in the Sanger sequencing of genomes. NGS is fundamentally based on sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing.

Stakeholders

  • NGS instrument manufacturers, vendors, and distributors
  • NGS service providers
  • NGS bioinformatics/data analysis companies
  • Research laboratories and academic institutes
  • Venture capitalists and other government funding organizations
  • Research and consulting firms
  • Healthcare institutions (hospitals and diagnostic clinics)
  • Pharmaceutical and biotechnology companies
  • Academic and government research institutes
  • Life science companies

Report Objectives

  • To define, describe, and forecast the next-generation sequencing market based on offerings, product type, platform technology, product workflow, product end user, service type, service workflow, service end user, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall next-generation sequencing market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the global next-generation sequencing market and comprehensively analyze their platforms, reagents, kits, consumables, and services portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the next-generation sequencing market
  • To benchmark players within the next-generation sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Previous Versions of this Report

Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2026

Report Code BT 2697
Published in Apr, 2021, By MarketsandMarkets™

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA), Technology (Ion, SMRT), Application (Diagnostics, Cancer), EndUser (Academia, Research) - Global Forecasts to 2024

Report Code BT 2697
Published in Nov, 2019, By MarketsandMarkets™

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024

Report Code BT 2697
Published in Aug, 2018, By MarketsandMarkets™

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

Report Code BT 2697
Published in Mar, 2017, By MarketsandMarkets™

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

Report Code BT 2697
Published in Mar, 2016, By MarketsandMarkets™

Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020

Report Code BT 2697
Published in Sep, 2014, By MarketsandMarkets™

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017

Report Code BT 2697
Published in Jun, 2013, By MarketsandMarkets™

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

Report Code BT 2697
Published in Jan, 2025, By MarketsandMarkets™

Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020

Report Code BT 2697
Published in Jan, 2011, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Next-Generation Sequencing Market

Jackson

May, 2022

Which company and region dominates the Next generation Sequencing Market ?.

James

May, 2022

What is the most popular next-generation sequencing platform today in Next generation Sequencing Market ?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status